Stock listing
Crescent Biopharma, Inc.
Selected listing: CBIO · NASDAQ · USD · US
Crescent Biopharma, Inc. (NASDAQ:CBIO), Health Technology. Latest release Oct 6, 2026: Crescent Biopharma Announces Grants of Inducement Awards.
- Ticker
- NASDAQ:CBIO
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Crescent Biopharma, Inc.
The company focuses on biopharmaceutical development and innovation. As part of the American market, Crescent Biopharma aims to advance healthcare through its research and product offerings.
Latest news from Crescent Biopharma, Inc.
Crescent Biopharma Announces Grants of Inducement Awards
October 6, 2026
Crescent Biopharma Announces FDA Clearance of IND Application for CR-002, a PD-L1-targeted Topoisomerase Inhibitor ADC, for the Treatment of Solid Tumors
October 5, 2026
Crescent Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights
July 29, 2026
Crescent Biopharma Announces Closing of Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
July 16, 2026
Crescent Biopharma Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants
July 14, 2026
Events
Research Crescent Biopharma, Inc.
Crescent Biopharma, Inc. company profile
View the public company page for Crescent Biopharma, Inc. on 6ix.
Crescent Biopharma, Inc. news
Read company news and market updates connected to Crescent Biopharma, Inc..
Crescent Biopharma, Inc. investor events
Find investor webinars, events, and replay context for Crescent Biopharma, Inc..
Alternate listings
A41BDZ:LS
DE · EUR
Alternate listing for Crescent Biopharma, Inc.; the primary context on this page is CBIO:NASDAQ.
CBIO:BOATS
US · USD
Alternate listing for Crescent Biopharma, Inc.; the primary context on this page is CBIO:NASDAQ.
C68:FWB
DE · EUR
Alternate listing for Crescent Biopharma, Inc.; the primary context on this page is CBIO:NASDAQ.
C68:GETTEX
DE · EUR
Alternate listing for Crescent Biopharma, Inc.; the primary context on this page is CBIO:NASDAQ.